none dosage 500 mg (equivalent to 562.43 mg sodium ascorbate) 1,000 iu/10 mg (equivalent to 70 mg zinc gluconate) dosage
metz pharmaceuticals, inc. - ascorbic acid , cholecalciferol , zinc - capsule classification: over-the-counter (otc) - 500 mg (equivalent to 562.43 mg sodium ascorbate) 1,000 iu/10 mg (equivalent to 70 mg zinc gluconate) dosage
new myrex laboratories, inc./ tgp pharma inc. kylezine clindamycin (as hydrochloride)
new myrex laboratories, inc. - drug - clindamycin (as hydrochloride) - kylezine
sincalide for injection powder for solution
avir pharma inc. - sincalide - powder for solution - 5mcg - sincalide 5mcg - gallbladder function
zinc 10 mg (equivalent to 70 mg zinc gluconate)/5 ml syrup (orange flavor)
euro-health care exponents, inc.; importer: n/a; distributor: tgp pharma, inc. - tgp zinc gluconate - syrup (orange flavor) - 10 mg (equivalent to 70 mg zinc gluconate)/5 ml
none 56 mg (equivalent to 20 mg elemental zinc)/5 ml syrup
remed pharmaceuticals, inc.; importer: n/a; distributor: n/a - zinc sulfate (as monohydrate) - syrup - 56 mg (equivalent to 20 mg elemental zinc)/5 ml
sincalide injection, powder, lyophilized, for solution
maia pharmaceuticals, inc. - sincalide (unii: m03giq7z6p) (sincalide - unii:m03giq7z6p) - sincalide for injection is indicated in adults to: - stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals; - stimulate pancreatic secretion in combination with secretin prior to obtaining a duodenal aspirate for analysis of enzyme activity, composition, and cytology; - accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract. sincalide for injection is contraindicated in patients with: - a history of a hypersensitivity reaction to sulfites or sincalide. serious hypersensitivity reactions have included anaphylaxis and anaphylactic shock [see warnings and precautions (5.1), adverse reactions (6)]. - intestinal obstruction. risk summary based on limited human data and mechanism of action, sincalide for inj
enerzinc 20 mg per 5 ml syrup (equivalent to 55 mg per 5 ml zinc sulfate monohydrate) syrup
alman pharmaceuticals, inc. - zinc (as sulfate monohydrate) - syrup - 20 mg per 5 ml syrup (equivalent to 55 mg per 5 ml zinc sulfate monohydrate)
zincavit 20 mg/5 ml (equivalent to 55 mg zinc sulfate monohydrate) syrup (orange flavor)
vitalink health products, inc.; distributor: altomed pharmaceuticals, inc. - zinc (as zinc sulfate monohydrate) - syrup (orange flavor) - 20 mg/5 ml (equivalent to 55 mg zinc sulfate monohydrate)
zincavit 10 mg/ml (equivalent to 27.5 mg zinc sulfate monohydrate) syrup (oral drops) (orange flavor)
vitalink health products, inc.; distributor: altomed pharmaceuticals, inc. - zinc (as zinc sulfate monohydrate) - syrup (oral drops) (orange flavor) - 10 mg/ml (equivalent to 27.5 mg zinc sulfate monohydrate)
none 10 mg (equivalent to 70 mg zinc gluconate) chewable tablet
metz pharmaceuticals inc. - zinc - chewable tablet - 10 mg (equivalent to 70 mg zinc gluconate)